Skip to main content
Erschienen in: Inflammation Research 9/2023

19.09.2023 | Original Research Paper

Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses

verfasst von: Xingwang Zhao, Mengjie Zhang, Yuying Jia, Wenying Liu, Shifei Li, Cuie Gao, Lian Zhang, Bing Ni, Zhihua Ruan, Rui Dong

Erschienen in: Inflammation Research | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Coronavirus disease 2019 (COVID-19) shares similar immune characteristics with autoimmune diseases like systemic lupus erythematosus (SLE). However, such associations have not yet been investigated at the single-cell level.

Methods

We integrated and analyzed RNA sequencing results from different patients and normal controls from the GEO database and identified subsets of immune cells that might involve in the pathogenesis of SLE and COVID- 19. We also disentangled the characteristic alterations in cell and molecular subset proportions as well as gene expression patterns in SLE patients compared with COVID-19 patients.

Results

Key immune characteristic genes (such as CXCL10 and RACK1) and multiple immune-related pathways (such as the coronavirus disease-COVID-19, T-cell receptor signaling, and MIF-related signaling pathways) were identified. We also highlighted the differences in peripheral blood mononuclear cells (PBMCs) between SLE and COVID-19 patients. Moreover, we provided an opportunity to comprehensively probe underlying B-cell‒cell communication with multiple ligand–receptor pairs (MIF-CD74+CXCR4, MIF-CD74+CD44) and the differentiation trajectory of B-cell clusters that is deemed to promote cell state transitions in COVID-19 and SLE.

Conclusions

Our results demonstrate the immune response differences and immune characteristic similarities, such as the cytokine storm, between COVID-19 and SLE, which might pivotally function in the pathogenesis of the two diseases and provide potential intervention targets for both diseases.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Doaty S, Agrawal H, Bauer E, et al. Infection and lupus: which causes which? Curr Rheumatol Rep. 2016;18(3):13.PubMedCrossRef Doaty S, Agrawal H, Bauer E, et al. Infection and lupus: which causes which? Curr Rheumatol Rep. 2016;18(3):13.PubMedCrossRef
2.
Zurück zum Zitat Sawalha AH, Zhao M, Coit P, et al. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020;215: 108410.PubMedPubMedCentralCrossRef Sawalha AH, Zhao M, Coit P, et al. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020;215: 108410.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Tiendrebeogo WJS, Kabore F, Diendere EA, et al. Case series of chronic inflammatory rheumatic disease patients infected by coronavirus disease 2019 (COVID-19). Case Rep Rheumatol. 2020;2020:8860492.PubMedPubMedCentral Tiendrebeogo WJS, Kabore F, Diendere EA, et al. Case series of chronic inflammatory rheumatic disease patients infected by coronavirus disease 2019 (COVID-19). Case Rep Rheumatol. 2020;2020:8860492.PubMedPubMedCentral
6.
Zurück zum Zitat Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–62.PubMedCrossRef Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–62.PubMedCrossRef
8.
Zurück zum Zitat Shayestehpour M, Zamani B. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021;93(5):2599.PubMedPubMedCentralCrossRef Shayestehpour M, Zamani B. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021;93(5):2599.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Spihlman AP, Gadi N, Wu SC, et al. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol. 2020;11: 589474.PubMedPubMedCentralCrossRef Spihlman AP, Gadi N, Wu SC, et al. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol. 2020;11: 589474.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Misra DP, Agarwal V, Gasparyan AY, et al. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020;39(7):2055–62.PubMedPubMedCentralCrossRef Misra DP, Agarwal V, Gasparyan AY, et al. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020;39(7):2055–62.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Gkogkou E, Barnasas G, Vougas K, et al. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol. 2020;36: 101615.PubMedPubMedCentralCrossRef Gkogkou E, Barnasas G, Vougas K, et al. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol. 2020;36: 101615.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Dendrou CA, Petersen J, Rossjohn J, et al. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325–39.PubMedCrossRef Dendrou CA, Petersen J, Rossjohn J, et al. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325–39.PubMedCrossRef
16.
Zurück zum Zitat McHugh J. New evidence for the “cusp theory” to explain HLA associations in SLE. Nat Rev Rheumatol. 2022;18(10):552.PubMedCrossRef McHugh J. New evidence for the “cusp theory” to explain HLA associations in SLE. Nat Rev Rheumatol. 2022;18(10):552.PubMedCrossRef
17.
Zurück zum Zitat Deb P, Zannat KE, Talukder S, et al. Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID-19: a systematic review. HLA. 2022;99(4):281–312.PubMedCrossRef Deb P, Zannat KE, Talukder S, et al. Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID-19: a systematic review. HLA. 2022;99(4):281–312.PubMedCrossRef
19.
Zurück zum Zitat Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35–45.PubMedCrossRef Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35–45.PubMedCrossRef
20.
Zurück zum Zitat Wang Y, Xie X, Zhang C, et al. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren’s syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis. 2022;81(3):379–85.PubMedCrossRef Wang Y, Xie X, Zhang C, et al. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren’s syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis. 2022;81(3):379–85.PubMedCrossRef
21.
Zurück zum Zitat Der E, Suryawanshi H, Morozov P, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20(7):915–27.PubMedPubMedCentralCrossRef Der E, Suryawanshi H, Morozov P, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20(7):915–27.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat He Y, Jiang Z, Chen C, et al. Classification of triple-negative breast cancers based on Immunogenomic profiling. J Exp Clin Cancer Res. 2018;37(1):327.PubMedPubMedCentralCrossRef He Y, Jiang Z, Chen C, et al. Classification of triple-negative breast cancers based on Immunogenomic profiling. J Exp Clin Cancer Res. 2018;37(1):327.PubMedPubMedCentralCrossRef
23.
24.
Zurück zum Zitat Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.PubMedPubMedCentralCrossRef Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Bhattacharya S, Andorf S, Gomes L, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2–3):234–9.PubMedCrossRef Bhattacharya S, Andorf S, Gomes L, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2–3):234–9.PubMedCrossRef
28.
30.
Zurück zum Zitat Zhang X, Lan Y, Xu J, et al. Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721–8.PubMedCrossRef Zhang X, Lan Y, Xu J, et al. Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721–8.PubMedCrossRef
31.
Zurück zum Zitat Clarke ZA, Andrews TS, Atif J, et al. Tutorial: guidelines for annotating single-cell transcriptomic maps using automated and manual methods. Nat Protoc. 2021;16(6):2749–64.PubMedCrossRef Clarke ZA, Andrews TS, Atif J, et al. Tutorial: guidelines for annotating single-cell transcriptomic maps using automated and manual methods. Nat Protoc. 2021;16(6):2749–64.PubMedCrossRef
32.
33.
Zurück zum Zitat Shao X, Liao J, Lu X, et al. scCATCH: automatic annotation on cell types of clusters from single-cell RNA sequencing data. Science. 2020;23(3): 100882. Shao X, Liao J, Lu X, et al. scCATCH: automatic annotation on cell types of clusters from single-cell RNA sequencing data. Science. 2020;23(3): 100882.
34.
Zurück zum Zitat Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–7.PubMedPubMedCentralCrossRef Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–7.PubMedPubMedCentralCrossRef
35.
36.
Zurück zum Zitat Efremova M, Vento-Tormo M, Teichmann SA, et al. Cell PhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat Protoc. 2020;15(4):1484–506.PubMedCrossRef Efremova M, Vento-Tormo M, Teichmann SA, et al. Cell PhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat Protoc. 2020;15(4):1484–506.PubMedCrossRef
37.
Zurück zum Zitat Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381–6.PubMedPubMedCentralCrossRef Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381–6.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Ramalho R, Rao M, Zhang C, et al. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol. 2020;42(3):279–313.PubMedPubMedCentralCrossRef Ramalho R, Rao M, Zhang C, et al. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol. 2020;42(3):279–313.PubMedPubMedCentralCrossRef
42.
43.
Zurück zum Zitat Omarjee L, Perrot F, Meilhac O, et al. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging (Albany NY). 2020;12(24):26263–78.PubMedCrossRef Omarjee L, Perrot F, Meilhac O, et al. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging (Albany NY). 2020;12(24):26263–78.PubMedCrossRef
44.
45.
Zurück zum Zitat Zhang N, Zhao YD, Wang XM. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients. Eur Rev Med Pharmacol Sci. 2020;24(13):7497–505.PubMed Zhang N, Zhao YD, Wang XM. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients. Eur Rev Med Pharmacol Sci. 2020;24(13):7497–505.PubMed
47.
Zurück zum Zitat Oliviero A, de Castro F, Coperchini F, et al. COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator? Neuroscientist. 2021;27(3):214–21.PubMedCrossRef Oliviero A, de Castro F, Coperchini F, et al. COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator? Neuroscientist. 2021;27(3):214–21.PubMedCrossRef
48.
Zurück zum Zitat Blot M, Jacquier M, Glele LA, et al. Correction to: CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS. Crit Care. 2021;25(1):143.PubMedPubMedCentralCrossRef Blot M, Jacquier M, Glele LA, et al. Correction to: CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS. Crit Care. 2021;25(1):143.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Li S, Duan X, Li Y, et al. Differentially expressed immune response genes in COVID-19 patients based on disease severity. Aging (Albany NY). 2021;13(7):9265–76.PubMedCrossRef Li S, Duan X, Li Y, et al. Differentially expressed immune response genes in COVID-19 patients based on disease severity. Aging (Albany NY). 2021;13(7):9265–76.PubMedCrossRef
50.
Zurück zum Zitat Zhang R, Li Y, Pan B, et al. Increased expression of hub gene CXCL10 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Exp Ther Med. 2019;18(5):4067–75.PubMedPubMedCentral Zhang R, Li Y, Pan B, et al. Increased expression of hub gene CXCL10 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Exp Ther Med. 2019;18(5):4067–75.PubMedPubMedCentral
51.
Zurück zum Zitat Welcher AA, Boedigheimer M, Kivitz AJ, et al. Blockade of interferon-gamma normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(10):2713–22.PubMedPubMedCentralCrossRef Welcher AA, Boedigheimer M, Kivitz AJ, et al. Blockade of interferon-gamma normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(10):2713–22.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Tavasolian F, Rashidi M, Hatam GR, et al. HLA, immune response, and susceptibility to COVID-19. Front Immunol. 2020;11: 601886.PubMedCrossRef Tavasolian F, Rashidi M, Hatam GR, et al. HLA, immune response, and susceptibility to COVID-19. Front Immunol. 2020;11: 601886.PubMedCrossRef
54.
Zurück zum Zitat Huang X, Luu LDW, Jia N, et al. Multi-platform omics analysis reveals molecular signatures for pathogenesis and activity of systemic lupus erythematosus. Front Immunol. 2022;13: 833699.PubMedPubMedCentralCrossRef Huang X, Luu LDW, Jia N, et al. Multi-platform omics analysis reveals molecular signatures for pathogenesis and activity of systemic lupus erythematosus. Front Immunol. 2022;13: 833699.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Ambegaonkar AA, Holla P, Dizon BL, et al. Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces. Curr Opin Immunol. 2022;77: 102227.PubMedPubMedCentralCrossRef Ambegaonkar AA, Holla P, Dizon BL, et al. Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces. Curr Opin Immunol. 2022;77: 102227.PubMedPubMedCentralCrossRef
56.
57.
Zurück zum Zitat Shue B, Chiramel AI, Cerikan B, et al. Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. J Virol. 2021;95(24): e0059621.PubMedCrossRef Shue B, Chiramel AI, Cerikan B, et al. Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. J Virol. 2021;95(24): e0059621.PubMedCrossRef
58.
Zurück zum Zitat Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron. Cell. 2022;185(5):847–59.e11.PubMedPubMedCentralCrossRef Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron. Cell. 2022;185(5):847–59.e11.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Feldman J, Bals J, Altomare CG, et al. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Sci Immunol. 2021;6(66): eabl5842.PubMedPubMedCentralCrossRef Feldman J, Bals J, Altomare CG, et al. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Sci Immunol. 2021;6(66): eabl5842.PubMedPubMedCentralCrossRef
60.
61.
Zurück zum Zitat Scheid JF, Barnes CO, Eraslan B, et al. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell. 2021;184(12):3205–21.e24.PubMedPubMedCentralCrossRef Scheid JF, Barnes CO, Eraslan B, et al. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell. 2021;184(12):3205–21.e24.PubMedPubMedCentralCrossRef
Metadaten
Titel
Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses
verfasst von
Xingwang Zhao
Mengjie Zhang
Yuying Jia
Wenying Liu
Shifei Li
Cuie Gao
Lian Zhang
Bing Ni
Zhihua Ruan
Rui Dong
Publikationsdatum
19.09.2023
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 9/2023
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-023-01791-3

Weitere Artikel der Ausgabe 9/2023

Inflammation Research 9/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.